| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |